CAS RN: 60462-19-3
METHYL 4-HYDROXYMETHYLCUBANECARBOXYLATE
Product Availability
Choose a grade to view its available package options.
4 package records4 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251121 |
100mg |
In stock |
Shanghai, Shenzhen, Tianjin | Inquiry |
| Batchno.20260628 |
1g |
In stock |
Shanghai, Shenzhen, Chengdu | Inquiry |
| Batchno.20260322 |
250mg |
In stock |
Shenzhen, Tianjin, Chengdu | Inquiry |
| Batchno.20250708 |
50mg |
In stock |
Shanghai | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.05g, 0.1g, 0.25g, 1g
- Available purity: >97%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 60462-19-3
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.05g |
>97% |
1
In Stock
|
Shanghai |
Inquiry |
| 0.1g |
>97% |
1
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
>97% |
1
In Stock
|
Shanghai |
Inquiry |
| 1g |
>97% |
1
In Stock
|
Shanghai |
Inquiry |
60462-19-3 / methyl 4-(hydroxymethyl)cubane-1-carboxylate
Standard CAS: 60462-19-3
Multi CAS: No
Basic Information
CAS
60462-19-3
Multi CAS
No
Molecular Formula
C11H12O3
Molecular Weight
192.210000
Exact Mass
192.078644
InChI
InChI=1S/C11H12O3/c1-14-9(13)11-6-3-7(11)5-8(11)4(6)10(3,5)2-12/h3-8,12H,2H2,1H3
InChIKey
JYRRBVFDZGSZBE-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
14
Fraction Csp3
0.91
Rotatable bonds
2
H-bond acceptors
3
H-bond donors
1
Molar refractivity
44.91
TPSA
46.53
LogP / Solubility
WLOGP
-0.11
MLOGP
-0.1
XLogP3
-0.2
Consensus LogP
-0.14
Log S (ESOL)
-0.83
Class (ESOL)
Very soluble
Log S (Ali)
-1.06
Class (Ali)
Soluble
Log S (SILICOS-IT)
-1.06
Class (SILICOS-IT)
Soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.97
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3